Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer
NCT00872495
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to determine if analysis of DNA and protein material found in urine will be useful in the detection of urothelial cancer of the bladder and kidney. This analysis may be helpful to determine if how a particular cancer will act regarding remission and recurrence
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Urothelial Cancer
- Cancer
- Bladder Neoplasms
- Urinary Bladder Cancer
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Lahey Clinic
- Last updated on ClinicalTrials.gov
- December 8, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Massachusetts · 1
- Lahey Clinic, Inc. · Burlington, MA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.